Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19-Reference-Cited by-同舟云学术

Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19

Published:2022-07-11 Issue:8 Volume:42 Page:693-695
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Berar Yanay Noa^ORCID,Bogner Ido,Saker Khader,Tannous Elias

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01180-4.pdf

Reference9 articles.

1. Sheiner LB, Beal SL. Bayesian individualization of pharmacokinetics. Simple implementation and comparison with non-Bayesian methods. J Pharm Sci. 1982;71:1344–8.

2. Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, et al. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. Br J Clin Pharmacol. 2014;78(3):509–23.

3. Le Louedec F. mapbayr: MAP-Bayesian estimation of PK parameters. R package version 0.5.0. 2021. https://CRAN.Rproject.org/package=mapbayr. Accessed 6 Jul 2022.

4. Goffin E, Candellier A, Vart P, Noordzij M, Arnol M, Covic A, Lentini P, on behalf of ERACODA Collaborators. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study. Nephrol Dial Transplant. 2021;36:2094–105. https://doi.org/10.1093/ndt/gfab200.

5. Quiroga B, Soler MJ, Ortiz A, Vaquera SM, Jarava Mantecon CJ, Useche G, et al. Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study. Nephrol Dial Transplant. 2021. https://doi.org/10.1093/ndt/gfab313.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report;Journal of Infection and Chemotherapy;2024-09

2. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus;Frontiers in Pharmacology;2024-06-19

3. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients;European Journal of Clinical Pharmacology;2024-05-01

4. Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review;Infectious Diseases and Therapy;2024-04-12

5. Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19;Frontiers in Medicine;2024-04-03